Brief: Astria Therapeutics Picks Ypsomed’s YpsoMate as Injection Device for STAR-0215
12/08/2024 21:16
Aug 12 (Reuters) - Astria Therapeutics Inc ATXS.O :
* ASTRIA THERAPEUTICS CHOOSES YPSOMED’S YPSOMATE AS THE
INJECTION
DEVICE FOR STAR-0215 FOR THE TREATMENT OF HEREDITARY ANGIOEDEMA
Source text for Eikon: ID:nBw5r8589a
Further company coverage: ATXS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astria Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 07:59 PM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM